Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
The Muscular System01:18

The Muscular System

7.0K
The muscular system is essential to the body's overall structure and function, playing a crucial role in movement, stability, and internal processes. It consists of three distinct types of muscle tissue: the skeletal, the smooth, and the cardiac muscles.
7.0K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

29.7K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.7K
Sample Preparation for Analysis: Advanced Techniques01:08

Sample Preparation for Analysis: Advanced Techniques

1.4K
Accurate analysis of complex samples often requires advanced preparation techniques to achieve reliable and reproducible results. Samples containing inorganic or organic materials can be challenging to dissolve or decompose effectively. Standard sample preparation methods include acid digestion, fusion, dry ashing, and wet digestion.
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
1.4K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

524
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of aryl-fused bicyclo[3.1.1]heptanes and validation as naphthyl bioisosteres.

Nature chemistry·2026
Same author

Retraction notice to "Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial" [J. Clin. Virol. 155C (2022) 105248].

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2025
Same author

Corrigendum to "Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene" Neuromuscular Disorders 39 (2024) 5-9.

Neuromuscular disorders : NMD·2024
Same author

Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene.

Neuromuscular disorders : NMD·2024
Same author

Personal journeys to and in human genetics and dysmorphology.

American journal of medical genetics. Part A·2024
Same author

Therapeutic approaches for Duchenne muscular dystrophy.

Nature reviews. Drug discovery·2023

Related Experiment Video

Updated: Jan 27, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.8K

Recent advances in Duchenne muscular dystrophy.

Kelly J Perkins1,2, Kay E Davies2

  • 1Sir William Dunn School of Pathology.

Degenerative Neurological and Neuromuscular Disease
|March 21, 2019
PubMed
Summary

Duchenne muscular dystrophy (DMD) treatments are advancing with gene and cell therapies aiming to correct the underlying genetic defect. While clinical use is pending, these innovative strategies show promise for treating this progressive muscle-wasting disease.

Keywords:
animal modelsdystrophyexon skippinggene therapypharmacologicalutrophin

More Related Videos

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy
05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.2K

Related Experiment Videos

Last Updated: Jan 27, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.8K
A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy
05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.2K

Area of Science:

  • Biomedical Science
  • Genetics
  • Regenerative Medicine

Background:

  • Duchenne muscular dystrophy (DMD) is a common, X-linked, progressive muscle-wasting disease caused by the lack of dystrophin protein.
  • Current clinical interventions for DMD focus on symptom management, lacking a cure for the primary genetic defect.

Purpose of the Study:

  • To review recent therapeutic strategies for Duchenne muscular dystrophy.
  • To highlight advancements in gene- and cell-based therapies, RNA-based approaches, and pharmacological interventions.
  • To discuss preclinical and clinical progress, challenges, and synergistic approaches for DMD treatment.

Main Methods:

  • Review of gene replacement and endogenous modification strategies, including improvements in delivery and efficiency.
  • Analysis of RNA-based modifying approaches like exon skipping for functional dystrophin protein expression.
  • Evaluation of emerging combined gene- and cell-therapy strategies for ex vivo genetic correction and autologous transplantation.
  • Assessment of pharmacological approaches targeting functional replacement or secondary pathology amelioration.
  • Consideration of insights from animal models and recent clinical trials in DMD patients.

Main Results:

  • Gene and cell-based therapeutics demonstrate significant promise for correcting the primary defect in DMD.
  • RNA-based modifying approaches, such as exon skipping, are progressing rapidly toward clinical application.
  • Combined gene- and cell-therapy strategies offer potential to overcome immune challenges through ex vivo correction and autologous transplantation.
  • Pharmacological interventions are identifying molecules for functional replacement and amelioration of secondary DMD pathology.
  • While no therapy has reached clinical use, rapid technological advancements are accelerating progress.

Conclusions:

  • Innovative therapeutic strategies, including gene, cell, and RNA-based approaches, hold substantial promise for Duchenne muscular dystrophy.
  • Continued research and development, informed by preclinical and clinical studies, are crucial for overcoming challenges and achieving effective DMD treatments.
  • Synergistic approaches combining multiple therapeutic modalities are being devised to combat dystrophic pathology more effectively.